351 related articles for article (PubMed ID: 16831601)
1. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.
Ogata H; Kobayashi T; Chinen T; Takaki H; Sanada T; Minoda Y; Koga K; Takaesu G; Maehara Y; Iida M; Yoshimura A
Gastroenterology; 2006 Jul; 131(1):179-93. PubMed ID: 16831601
[TBL] [Abstract][Full Text] [Related]
2. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production.
Ogata H; Chinen T; Yoshida T; Kinjyo I; Takaesu G; Shiraishi H; Iida M; Kobayashi T; Yoshimura A
Oncogene; 2006 Apr; 25(17):2520-30. PubMed ID: 16474852
[TBL] [Abstract][Full Text] [Related]
3. HBV-induced ROS accumulation promotes hepatocarcinogenesis through Snail-mediated epigenetic silencing of SOCS3.
Yuan K; Lei Y; Chen HN; Chen Y; Zhang T; Li K; Xie N; Wang K; Feng X; Pu Q; Yang W; Wu M; Xiang R; Nice EC; Wei Y; Huang C
Cell Death Differ; 2016 Apr; 23(4):616-27. PubMed ID: 26794444
[TBL] [Abstract][Full Text] [Related]
4. SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma.
Zhang X; You Q; Zhang X; Chen X
Int J Mol Sci; 2015 Sep; 16(9):22662-75. PubMed ID: 26393582
[TBL] [Abstract][Full Text] [Related]
5. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.
Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B
J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis.
Torisu T; Nakaya M; Watanabe S; Hashimoto M; Yoshida H; Chinen T; Yoshida R; Okamoto F; Hanada T; Torisu K; Takaesu G; Kobayashi T; Yasukawa H; Yoshimura A
Hepatology; 2008 May; 47(5):1644-54. PubMed ID: 18393318
[TBL] [Abstract][Full Text] [Related]
7. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
[TBL] [Abstract][Full Text] [Related]
8. FXR induces SOCS3 and suppresses hepatocellular carcinoma.
Guo F; Xu Z; Zhang Y; Jiang P; Huang G; Chen S; Lyu X; Zheng P; Zhao X; Zeng Y; Wang S; He F
Oncotarget; 2015 Oct; 6(33):34606-16. PubMed ID: 26416445
[TBL] [Abstract][Full Text] [Related]
9. Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3.
Riehle KJ; Campbell JS; McMahan RS; Johnson MM; Beyer RP; Bammler TK; Fausto N
J Exp Med; 2008 Jan; 205(1):91-103. PubMed ID: 18158318
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
[TBL] [Abstract][Full Text] [Related]
11. Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma.
Cui Q; Jiang W; Wang Y; Lv C; Luo J; Zhang W; Lin F; Yin Y; Cai R; Wei P; Qian C
Hepatology; 2008 Jan; 47(1):105-12. PubMed ID: 17935223
[TBL] [Abstract][Full Text] [Related]
12. Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity.
Sachithanandan N; Fam BC; Fynch S; Dzamko N; Watt MJ; Wormald S; Honeyman J; Galic S; Proietto J; Andrikopoulos S; Hevener AL; Kay TW; Steinberg GR
Hepatology; 2010 Nov; 52(5):1632-42. PubMed ID: 20799351
[TBL] [Abstract][Full Text] [Related]
13. SOCS3 in T and NKT cells negatively regulates cytokine production and ameliorates ConA-induced hepatitis.
Nakaya M; Hashimoto M; Nakagawa R; Wakabayashi Y; Ishizaki T; Takada I; Komai K; Yoshida H; Yoshimura A
J Immunol; 2009 Dec; 183(11):7047-53. PubMed ID: 19915050
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation.
Radaeva S; Sun R; Pan HN; Hong F; Gao B
Hepatology; 2004 May; 39(5):1332-42. PubMed ID: 15122762
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver.
Koeberlein B; zur Hausen A; Bektas N; Zentgraf H; Chin R; Nguyen LT; Kandolf R; Torresi J; Bock CT
Virus Res; 2010 Mar; 148(1-2):51-9. PubMed ID: 20005910
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3.
Jiang R; Tan Z; Deng L; Chen Y; Xia Y; Gao Y; Wang X; Sun B
Hepatology; 2011 Sep; 54(3):900-9. PubMed ID: 21674558
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E
Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818
[TBL] [Abstract][Full Text] [Related]
19. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma.
Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K
J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874
[TBL] [Abstract][Full Text] [Related]
20. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.
Rigby RJ; Simmons JG; Greenhalgh CJ; Alexander WS; Lund PK
Oncogene; 2007 Jul; 26(33):4833-41. PubMed ID: 17297444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]